ICON Bruce Given

Bruce Given appointed chairman of ICON

pharmafile | January 18, 2010 | Appointment | Research and Development ICON, appointment, research and development 

Irish contract research organisation ICON has appointed Bruce Given chairman.

He succeeds out-going chairman John Climax who co-founded the company in 1990 with former chairman Ronan Lambe, and will retire but remain on ICON’s board.

Given said: “We are extremely grateful for the extraordinary leadership and commitment that John has provided to ICON in his 20 years with the company, first as its co-founder and chief executive, and over the past seven years in his role as chairman.

“His vision and passionate commitment to ICON’s performance, people and clients have been the cornerstones of our success and we are delighted that he will remain on the board to help us forge a successful future for the company. It is an honour to succeed him.”

Given has been an ICON board member since 2004 and was most recently a healthcare products consultant.

From 2002 to 2007 he was president and chief executive of US firm Encysive Pharmaceuticals and prior to that spent nine years at Johnson & Johnson in a variety of roles.

He has also held various executive and senior management positions at Sandoz Pharma, Sandoz Research Institute and Schering-Plough Corporation. Prior to entering the pharmaceutical industry, he was on the medical faculty at the University of Chicago.

Related Content

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

funk

Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content